Semi-Annual Statement Of Cash Flows

Perseus Proteomics Inc. - Filing #7246059

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-902,340,000 JPY
-1,102,533,000 JPY
Depreciation
2,846,000 JPY
3,497,000 JPY
Impairment losses
72,510,000 JPY
153,887,000 JPY
Decrease (increase) in trade receivables
-8,554,000 JPY
-3,847,000 JPY
Decrease (increase) in inventories
-906,000 JPY
-1,229,000 JPY
Other, net
4,819,000 JPY
-42,398,000 JPY
Subtotal
-719,517,000 JPY
-832,018,000 JPY
Income taxes paid
-1,927,000 JPY
-1,927,000 JPY
Net cash provided by (used in) operating activities
-719,485,000 JPY
-833,898,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-75,157,000 JPY
-142,998,000 JPY
Net cash provided by (used in) investing activities
-75,157,000 JPY
-150,343,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-1,000 JPY
Net cash provided by (used in) financing activities
923,381,000 JPY
63,943,000 JPY
Effect of exchange rate change on cash and cash equivalents
-2,237,000 JPY
16,783,000 JPY
Net increase (decrease) in cash and cash equivalents
126,501,000 JPY
-903,514,000 JPY
Cash and cash equivalents
1,667,921,000 JPY
1,541,419,000 JPY
2,444,934,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.